Despite great strides in the development and wide acceptance of standards for exchanging structured information about genomic variants, there is no corresponding standard for exchanging phenotypic data, and this has impeded the sharing of phenotypic information for computational analysis. Here, we introduce the Global Alliance for Genomics and Health (GA4GH) Phenopacket schema, which supports exchange of computable longitudinal case-level phenotypic information for diagnosis and research of all types of disease including Mendelian and complex genetic diseases, cancer, and infectious diseases. To support translational research, diagnostics, and personalized healthcare, phenopackets are designed to be used across a comprehensive landscape of ...
The Global Alliance for Genomics and Health (GA4GH) aims to accelerate biomedical advances by enabli...
Rare disease patients are more likely to receive a rapid molecular diagnosis nowadays thanks to the ...
AbstractPersonalized medicine is the new horizon of the medical science. Its main goal is to improve...
Despite great strides in the development and wide acceptance of standards for exchanging structured ...
n the clinical domain, substantial work has been dedicated to the development of computational pheno...
The Global Alliance for Genomics and Health (GA4GH) is developing a suite of coordinated standards f...
<div><div><div><p>It is estimated 350 million people worldwide are afflicted with a rare disease. Be...
Less than half of patients with suspected genetic disease receive a molecular diagnosis. We have the...
Abstract Background With the advent of whole exome (ES) and genome sequencing (GS) as tools for dise...
The Global Alliance for Genomics and Health (GA4GH) aims to accelerate biomedical advances by enabli...
Rare disease patients are more likely to receive a rapid molecular diagnosis nowadays thanks to the ...
The Global Alliance for Genomics and Health (GA4GH) aims to accelerate biomedical advances by enabli...
Rare disease patients are more likely to receive a rapid molecular diagnosis nowadays thanks to the ...
AbstractPersonalized medicine is the new horizon of the medical science. Its main goal is to improve...
Despite great strides in the development and wide acceptance of standards for exchanging structured ...
n the clinical domain, substantial work has been dedicated to the development of computational pheno...
The Global Alliance for Genomics and Health (GA4GH) is developing a suite of coordinated standards f...
<div><div><div><p>It is estimated 350 million people worldwide are afflicted with a rare disease. Be...
Less than half of patients with suspected genetic disease receive a molecular diagnosis. We have the...
Abstract Background With the advent of whole exome (ES) and genome sequencing (GS) as tools for dise...
The Global Alliance for Genomics and Health (GA4GH) aims to accelerate biomedical advances by enabli...
Rare disease patients are more likely to receive a rapid molecular diagnosis nowadays thanks to the ...
The Global Alliance for Genomics and Health (GA4GH) aims to accelerate biomedical advances by enabli...
Rare disease patients are more likely to receive a rapid molecular diagnosis nowadays thanks to the ...
AbstractPersonalized medicine is the new horizon of the medical science. Its main goal is to improve...